Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia.
Tigu AB, Constantinescu CS, Teodorescu P, Kegyes D, Munteanu R, Feder R, Peters M, Pralea I, Iuga C, Cenariu D, Marcu A, Tanase A, Colita A, Drula R, Bergthorsson JT, Greiff V, Dima D, Selicean C, Rus I, Zdrenghea M, Gulei D, Ghiaur G, Tomuleasa C. Tigu AB, et al. Among authors: feder r. J Cell Mol Med. 2023 Oct;27(19):2864-2875. doi: 10.1111/jcmm.17810. Epub 2023 Sep 4. J Cell Mol Med. 2023. PMID: 37667538 Free PMC article.
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy.
Iluta S, Pasca S, Gafencu G, Jurj A, Terec A, Teodorescu P, Selicean C, Jitaru C, Preda A, Cenariu D, Constantinescu C, Iordache M, Tigu B, Munteanu R, Feder R, Dima D, Zdrenghea M, Gulei D, Ciuleanu TE, Tomuleasa C. Iluta S, et al. Among authors: feder r. J Cell Mol Med. 2021 Jul;25(13):6094-6102. doi: 10.1111/jcmm.16513. Epub 2021 Jun 16. J Cell Mol Med. 2021. PMID: 34132464 Free PMC article.
Current trends in luminescence-based assessment of apoptosis.
Moldovan C, Onaciu A, Toma V, Munteanu RA, Gulei D, Moldovan AI, Stiufiuc GF, Feder RI, Cenariu D, Iuga CA, Stiufiuc RI. Moldovan C, et al. Among authors: feder ri. RSC Adv. 2023 Oct 30;13(45):31641-31658. doi: 10.1039/d3ra05809c. eCollection 2023 Oct 26. RSC Adv. 2023. PMID: 37908656 Free PMC article. Review.
5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity.
Munteanu RA, Moldovan CS, Tigu AB, Drula R, Feder R, Magdo L, Jurj A, Raduly L, Budisan L, Pirlog R, Moldovan A, Zimta AA, Braicu C, Preda A, Munteanu V, Romitan M, Gulei D, Ciuleanu TE. Munteanu RA, et al. Among authors: feder r. Med Pharm Rep. 2024 Oct;97(4):488-506. doi: 10.15386/mpr-2777. Epub 2024 Oct 30. Med Pharm Rep. 2024. PMID: 39502764 Free PMC article.
151 results